Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Morgan, Jenna ^a   Wyld, Lynda ^a   Collins, Karen A ^b   Reed, Malcolm W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGED; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYSTITIS; FEMALE; HAIR LOSS; HEADACHE; HOT FLUSH; HUMAN; INDIGESTION; MASTALGIA; MASTECTOMY; META ANALYSIS; NAUSEA; OVERALL SURVIVAL; PARESTHESIA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PRURITUS; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; VAGINA DISCHARGE; VERTIGO;

EID: 84899642434     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004272.pub3     Document Type: Review

References (93)

1. Bates T, Fennessey M, Riley DL, Baum M, Houghton J, McRae K. Breast cancer in the elderly: surgery improves survival. The results of a cancer research campaign trial. European Journal of Cancer 2001;37(Suppl 5):7.
2. Bates T, Riley DL, Houghton J, Fallowfield L, Baum M. Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. British Journal of Surgery 1991;78(5):591-4.
3. Fallowfield L. Quality of life in the elderly woman with breast cancer treated with tamoxifen and surgery or tamoxifen alone. Journal of Women's Health 1994;3(1):17-20.
4. Fennessey M, Bates T, McRae K, Riley D, Houghton J, Baum M. Randomised trial of surgery plus tamoxifen versus tamoxifen-alone in women over age 70 with operable breast cancer. British Journal of Surgery 2004;91(6):699-704.
5. Riley D, Bates T, Houghton J. Breast cancer in the elderly patient - the case for clinical trials. The Breast 1995;4:253.
6. Riley D, Houghton J, Bates T. Breast cancer in the elderly patient - is there still a treatment dilemma?. British Journal of Cancer 1994;70(Suppl 22):23.
7. Fentiman IS. The nature and treatment of breast cancer in the elderly. Nowotwory 1994;44(Suppl 2):56-62.
8. Fentiman IS, Christiaens MR, Paridaens R, Van Geel A, Rutgers E, Berner J, et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. European Journal of Cancer 2003;39(3):309-16.
9. De Fabiani E, Giai M, Mustacchi G, Milani S, Sismondi P. Tamoxifen as sole treatment for localised breast cancer of the elderly: preliminary results of the Italian prospective randomized trial. European Journal of Gynaecological Oncology 1991;12 Suppl:59.
10. Mastacchi G. Hazard ratios and 95% confidence intervals [personal communication]. Email to: G Mustacchi 2005.
11. Mustacchi G, Ceccherini R, Milani S, Pluchinotta A, De Matteis A, Maiorino L, et al. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Annals of Oncology 2003;14(3):414-20.
12. Mustacchi G, Ceccherini R, Pluchinotta A, De Matteis A, Maiorino L, Farris A, et al. Results of adjuvant treatment in breast cancer women aged more than 70: Italian cooperative group experience. Tumori 2002;88 Suppl(1):83-5.
13. Mustacchi G, Mansutti M, Milani S, Pluchinotta A, Farris A, Scanni A, et al. Tamoxifene (tam) and primary breast cancer in old women. European Journal of Cancer 1990;26(2):169.
14. Mustacchi G, Milani S, Pluchinotta A, De Matteis A, Rubagotti A, Perrota A. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Research 1994;14(5B):2197-200.
15. Mustacchi G, Muggia M, Milani S, Pluchinotta A, Sismondi P, De Matteis A, et al. Tamoxifen and breast cancer of the elderly: Update of the Italian trial "G.R.E.T.A.". Breast Cancer Research & Treatment 1992;23(1/2):182.
16. Mustacchi G, Scanni A, Sismondi P, Milani S, Mansutti M, Farris A, et al. Tamoxifen (TAM) as sole treatment for primary breast cancer of the elderly: Preliminary data from the Italian multicentric trial "G.R.E.T.A.". Breast Cancer Research & Treatment 1991;19(2):174.
17. Capasso I, Nuzzo F, Labonia V, Landi G, Rossi E, De Matteis A. Surgery + tamoxifen versus tamoxifen as treatment of stage I and II breast cancer in over to 70 years old women: Ten years follow-up. Annals of Oncology 2000;11 Suppl(4):20.
18. Parisi V, De Matteis A, Grasso M, Scognamiglio F, Capasso I, Casciello M. Surgery + TAM versus TAM as treatment of stage I and II breast cancer in over 70 years old women. 5th European Conference on Clinical Oncology ECCO5: Federation of European Cancer Societies. 1989.
19. Thomas R, Capasso I, De Matteis A, Labonia V, Landi G, Nuzzo F, et al. Long term survival in elderly breast cancer patients treated with tamoxifen (TAM) alone vs surgery followed by TAM. European Journal of Cancer 1998;34:593.
20. Chakrabarti J, Kenny FS, Syed BM, Robertson JF, Blamey RW, Cheung KL. A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up. Critical Reviews in Oncology/Hematology 2011;78(3):260-4.
21. Kenny FS, Ellis IO, Elston CW, Robertson JFR, Blamey RW. Long term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. The Breast 1997;6(4):244.
22. Kenny FS, Robertson JFR, Ellis IO, Elston CW, Blamey RW. Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. The Breast 1998;7(6):335-9.
23. Robertson JF, Ellis IO, Elston CW, Blamey RW. Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. European Journal of Cancer 1992;28A(4-5):908-10.
24. Robertson JF, Todd JH, Ellis IO, Elston CW, Blamey RW. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. BMJ 1988;297(6647):511-4.
25. Robertson JFR, Blamey RW. Breast cancer, tamoxifen, and surgery. Lancet 1988;1(8593):1044.
26. Robertson JFR, Ellis IO, Nicholson RI, Elston CW, Blamey RW. Late results of a randomized crossover study of mastectomy or tamoxifen in elderly patients with operable breast cancer. Breast Cancer Research & Treatment 1990;16(2):176.
27. Robertson JFR, Todd JH, Ellis IO, Elston CW, Blamey RW. The treatment of the elderly patient with operable breast cancer. 5th EORTC Breast Cancer Working Conference. 1991; Vol. A:59.
28. Robertson JFR, Todd JH, Ellis IO, Nicholson RI, Elston CW, Blamey RW. Mastectomy or tamoxifen? A randomized crossover study in elderly patients with operable breast cancer. Breast Cancer Research & Treatment 1988;12(1):111.
29. Willsher PC, Robertson JFR, Jackson L, Al-Hilaly M, Blamey RW. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer. The Breast 1997;6:150-4.
30. Cannon PM, Low SC, Dixon A, Ellis IO, Elston CW, Blamey RW. Surgery versus tamoxifen in selected elderly patients with operable breast cancer: early results of a randomised trial. Breast Cancer Research & Treatment 1992;23(1/2):182.
31. Cannon PM, Low SC, Dixon A, Ellis IO, Elston CW, Blamey RW. Surgery versus tamoxifen in selected elderly patients with operable breast cancer: early results of a randomized trial. Irish Journal of Medical Science 1994;163(2):77.
32. Willsher PC, Robertson JFR, Jackson L, al Hilaly M, Blamey RW. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer. The Breast 1997;6:150-4.
33. Bland M. Anonymised IPD from which hazard ratios and 95% confidence intervals were derived [personal communication]. Email to: M Bland 2005.
34. Gazet JC, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, et al. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. European Journal of Surgical Oncology 1994;20(3):207-14.
35. Gazet JC, Markopoulos C, Ford HT, Coombes RC, Bland JM, Dixon RC. A prospective randomized trial of tamoxifen versus surgery in elderly patients with breast cancer - a preliminary report. 1st European Congress on Senology; 27-30 Mar 1988; Athens. 1988:140.
36. Gazet JC, Markopoulos C, Ford HT, Coombes RC, Bland JM, Dixon RC. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Lancet 1988;1(8587):679-81.
37. Gazet JC, Sutcliffe R. A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up. European Journal of Surgical Oncology 2011;37(9):754-7.
38. The ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
39. Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ 2000;321(7267):992-3.
40. West Midlands Cancer Intelligenve Unit. Breast Cancer Clinical Outcome Measures (BCCOM) Project: Analysis of the management of symptomatic breast cancers diagnosed in 2004. www.wmciu.nhs.uk/documents/BCCOM%20Year%203%20report.pdf (accessed 10th April 2014).
41. Bland M. Anonymised IPD from which hazard ratios and 95% confidence intervals were derived [personal communication]. Email to: M Bland 2005.
42. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schäfer P, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. Journal of Clinical Oncology 2003;21(19):3580-7.
43. Bradbeer JW, Kyngdon J. Primary treatment of breast cancer in elderly women with tamoxifen. Clinical Oncology 1983;9(1):31-4.
44. Bugeja G, Kumar A, Bannerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315(7115):1059.
45. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less post-operative morbidity compared with axillary lymph node dissection for breast cancer. American Journal of Surgery 2002;183(1):23-7.
46. Chakrabarti J, Kenny FS, Syed BM, Robertson JF, Blamey RW, Cheung KL. A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up. Critical Reviews in Oncology/Hematology 2011;78(3):260-4.
47. Craft PS, Zhang Y, Brogan J, Tait N, Buckingham JM. Implementing clinical practice guidelines: a community based audit of breast cancer treatment. Australian Capital Territory and South Eastern New South Wales Breast Cancer Treatment Group. Medical Journal of Australia 2000;172(5):213-6.
48. Crivellari D, Galligioni E, Foladore S, Errante D, Conte G, Nascimben O, et al. Treatment patterns in elderly patients (greater-than-or-equal-to 70 years) with breast-carcinoma - a retrospective study of the Gruppo-Oncologico-Clinico-Cooperativo-Del-Nord-Est (GOCCNE). Tumori 1991;77(2):136-40.
49. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women With breast cancer. Journal of the National Cancer Institute 2000;92(7):550-6.
50. Eiermann W, Paepke S, Appfelstaedt J, Llombart-Cussac A, Eremin J, Vinholes J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Annals of Oncology 2001;12(11):1527-32.
51. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrazole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value to the baseline PAM50-based intrinsic subtype - ACOSOG Z1031. Journal of Clinical Oncology 2011;29(17):2342-9.
52. Exterman M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients?. Journal of Clinical Oncology 2000;18(8):1709-17.
53. Fallowfield L. Quality of life in the elderly woman with breast cancer treated with tamoxifen and surgery or tamoxifen alone. Journal of Women's Health 1994;3(1):17-20.
54. Fennessey M, Bates T, McRae K, Riley D, Houghton J, Baum M. Randomised trial of surgery plus tamoxifen versus tamoxifen-alone in women over age 70 with operable breast cancer. British Journal of Surgery 2004;91(6):699-704.
55. Fentiman IS, Christiaens MR, Paridaens R, Van Geel A, Rutgers E, Berner J, et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. European Journal of Cancer 2003;39(3):309-16.
56. Garbay JR, Bertheault-Cvitkovic F, Cohen-Solal Le Nir C, Stevens D, Cherel P, Berlie J, et al. Treatment of breast cancer after 70 years of age. Report of 1143 cases. Chirurgie 2002;123(4):379-85.
57. Gaskell DJ, Sangster K, Hawkins RA, Chetty U, Forrest APM. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet 1989;1(8646):1044-6.
58. Gaskell DJ, Hawkins RA, De Carteret S, Chetty U, Sangster K, Forrest APM. Indications for primary tamoxifen in elderly women with breast cancer. British Journal of Surgery 1992;79(12):1317-20.
59. Gazet JC, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, et al. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. European Journal of Surgical Oncology 1994;20(3):207-14.
60. Gazet JC, Sutcliffe R. A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up. European Journal of Surgical Oncology 2011;37(9):754-7.
61. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010; Vol. 127, issue 12:2893-917.
62. Goldberg DP, Cooper B, Eastwood MR, Kedward HB, Shepherd M. A standardised psychiatric interview for use in community surveys. British Journal of Preventative and Social Medicine 1970;24(1):18-23.
63. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
64. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
65. Hooper SB, Hill AD, Kennedy S, Dijkstra B, Kelly LM, McDermott EW, et al. Tamoxifen as the primary treatment in elderly patients with breast cancer. Irish Journal of Medical Science 2002;171(1):28-30.
66. Husain LS, Collins K, Reed M, Wyld L. Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective. Psycho-oncology 2008;17(4):410-6.
67. Kenny FS, Robertson JFR, Ellis IO, Elston CW, Blamey RW. Long term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. The Breast 1998;7:335-9.
68. Kesseler HJ, Seton JZ. The treatment of operable breast cancer in the elderly female. American Journal of Surgery 1978;135(5):664-6.
69. McCarty KS Jr, Silva JS, Cox EB, Leight GS Jr, Wells SA Jr, McCarty KS Snr. Relationship of age and menopausal status to oestrogen receptor content in primary carcinoma of the breast. Annals of Surgery 1983;197(2):123-7.
70. Monypenny I on behalf of the BCCOM steering group. Breast Cancer Clinical Outcome Measures (BCCOM) Project. Analysis of the management of symptomatic breast cancers diagnosed in 2002. West Midlands Cancer Intelligence Unit 2006.
71. Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, et al. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. Journal of Clinical Oncology 2003;21(11):2101-9.
72. Mustacchi G, Latteier J, Milani S, Bates T, Houghton J. Tamoxifen versus surgery plus tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the "GRETA" and "CRC" trials. Proceedings of ASCO. 1998; Vol. 17:99a. [Abstract 383]
73. Mustacchi G, Ceccherini R, Milani S, Pluchinotta A, De Matteis A, Maiorino L, et al. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Annals of Oncology 2003;14(3):414-20.
74. Mastacchi G. Hazard ratios and 95% confidence intervals [personal communication]. Email to: G Mustacchi 2005.
75. NHS Information Centre. National Mastectomy and Breast Reconstruction Audit. www.hscic.gov.uk/catalogue/PUB02731/clin-audi-supp-prog-mast-brea-reco-2011-rep1.pdf (Accessed 10th April 2014).
76. National Institute for Clinical Excellence (NICE). Guidance on Cancer Services: Improving Outcomes in Breast Cancer. Manual update. London: NICE, 2002.
77. Oakley N, Dennison AR, Shorthouse AJ. A prospective audit of simple mastectomy under local anaesthesia. European Journal of Surgical Oncology 1996;22(2):134-6.
78. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
79. Preece PE, Wood RAB, Mackie CR, Cushieri A. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study. British Medical Journal (Clinical research ed.) 1982;284(6319):869-70.
80. Reed MW, Wyld L, Ellis P, Bliss J, Leonard R. Breast cancer in older women: trials and tribulations. Clinical Oncology (Royal College of Radiologists) 2009;21(2):99-102.
81. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
82. Sader C, Ingram D, Hastrich D. Management of breast cancer in the elderly by complete local excision and tamoxifen alone. Australia and New Zealand Journal of Surgery 1999;69(11):790-3.
83. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Annals of Internal Medicine 1994;120(2):104-10.
84. Silliman RA, Balducci L, Goodwin JS, Holmes FF, Leventhal EA. Breast cancer care in old age: What we know, don't know and do. Journal of the National Cancer Institute 1993;85(3):190-9.
85. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale RW, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer 1995;76(2):259-67.
86. Union Internationale Contre le Cancer. Breast tumours. In: Sobin LH, Gospodarowicz MK, Wittekind C editor(s). The TNM Classification of Malignant Tumours. 7th Edition. Oxford: Wiley-Blackwell, 2009:181-193.
87. Van Dalsen A, de Vries J. Treatment of breast cancer in elderly patients. Journal of Surgical Oncology 1995;60(2):80-2.
88. Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, et al. Is surgical management compromised in elderly patients with breast cancer?. Annals of Surgery 1997;225(5):579-89.
89. Willsher PC, Robertson JFR, Jackson L, al Hilaly M, Blamey RW. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer. The Breast 1997;6:150-4.
90. Wyld L, Reed MW. The need for targeted research into breast cancer in the elderly. British Journal of Surgery 2003;90(4):388-99.
91. Wyld L, Garg DK, Kumar ID, Brown H, Reed MW. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. British Journal of Cancer 2004;90(8):1486-91.
92. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Progress in Cardiovascular Diseases 1985;27(5):335-371.
93. Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD004272.pub2]